InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 04/07/2022

Re: None

Tuesday, 04/19/2022 6:21:11 PM

Tuesday, April 19, 2022 6:21:11 PM

Post# of 547
John’s Hopkins is involved w phase 2 - Clinical Trials.gov
3 Recruiting Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty
Conditions:
Sarcopenia
Frailty
Aging
Interventions:
Drug: MYMD-1 600MG
Drug: MYMD-1 750mg
Drug: MYMD-1 900mg
(and 5 more...)
Locations:
Clinical Research of West Florida, Inc
Clearwater, Florida, United States
Clinical Research of West Florida
Tampa, Florida, United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News